Annual CFF
$53.18 M
-$68.44 M-56.27%
31 December 2022
Summary:
Rain Therapeutics annual cash flow from financing activities is currently $53.18 million, with the most recent change of -$68.44 million (-56.27%) on 31 December 2022. During the last 3 years, it has fallen by -$16.31 million (-23.47%).RAIN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$0.00
-$12.00 K-100.00%
30 September 2023
Summary:
Rain Therapeutics quarterly cash flow from financing activities is currently $0.00, with the most recent change of -$12.00 thousand (-100.00%) on 30 September 2023.RAIN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$53.09 M
-$162.00 K-0.30%
30 September 2023
Summary:
Rain Therapeutics TTM cash flow from financing activities is currently $53.09 million, with the most recent change of -$162.00 thousand (-0.30%) on 30 September 2023.RAIN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAIN Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -23.5% | 0.0% | -56.3% |
| 5 y5 years | - | - | - |
RAIN Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -56.3% | -100.0% | -71.3% |
Rain Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $0.00(-100.0%) | $53.09 M(-0.3%) |
| June 2023 | - | $12.00 K(-97.4%) | $53.25 M(0.0%) |
| Mar 2023 | - | $466.00 K(-99.1%) | $53.25 M(+0.1%) |
| Dec 2022 | $53.18 M(-56.3%) | $52.61 M(>+9900.0%) | $53.18 M(+8632.3%) |
| Sept 2022 | - | $162.00 K(+1250.0%) | $609.00 K(+36.2%) |
| June 2022 | - | $12.00 K(-97.0%) | $447.00 K(-99.6%) |
| Mar 2022 | - | $399.00 K(+1008.3%) | $122.87 M(+1.0%) |
| Dec 2021 | $121.61 M | $36.00 K(>+9900.0%) | $121.61 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $0.00(-100.0%) | $121.55 M(-34.2%) |
| June 2021 | - | $122.44 M(<-9900.0%) | $184.73 M(+169.2%) |
| Mar 2021 | - | -$858.00 K(+3077.8%) | $68.63 M(-1.2%) |
| Dec 2020 | $69.49 M(+2679.6%) | -$27.00 K(-100.0%) | $69.49 M(-0.0%) |
| Sept 2020 | - | $63.18 M(+896.3%) | $69.52 M(+996.3%) |
| June 2020 | - | $6.34 M(>+9900.0%) | $6.34 M(>+9900.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $2.50 M | - | - |
FAQ
- What is Rain Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Rain Therapeutics?
- What is Rain Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Rain Therapeutics?
- What is Rain Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Rain Therapeutics?
What is Rain Therapeutics annual cash flow from financing activities?
The current annual CFF of RAIN is $53.18 M
What is the all time high annual CFF for Rain Therapeutics?
Rain Therapeutics all-time high annual cash flow from financing activities is $121.61 M
What is Rain Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of RAIN is $0.00
What is the all time high quarterly CFF for Rain Therapeutics?
Rain Therapeutics all-time high quarterly cash flow from financing activities is $122.44 M
What is Rain Therapeutics TTM cash flow from financing activities?
The current TTM CFF of RAIN is $53.09 M
What is the all time high TTM CFF for Rain Therapeutics?
Rain Therapeutics all-time high TTM cash flow from financing activities is $184.73 M